Fig. 3From: EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinomaa distribution of the main genetic alterations among the 1047 patients tested for EGFR, KRAS and BRAF mutations. b distribution of genetic alterations among the 788 samples tested for ALK and cMET alterationsBack to article page